174 related articles for article (PubMed ID: 33829340)
1. Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.
Gazaille C; Sicot M; Akiki M; Lautram N; Dupont A; Saulnier P; Eyer J; Bastiat G
Pharm Res; 2021 Apr; 38(4):681-691. PubMed ID: 33829340
[TBL] [Abstract][Full Text] [Related]
2. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
3. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.
Carradori D; Saulnier P; Préat V; des Rieux A; Eyer J
J Control Release; 2016 Sep; 238():253-262. PubMed ID: 27503706
[TBL] [Abstract][Full Text] [Related]
4. The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2019 Jul; 566():218-228. PubMed ID: 31132447
[TBL] [Abstract][Full Text] [Related]
5. Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.
Griveau A; Alnemeh-Al Ali H; Jourdain MA; Dupont A; Eyer J
Int J Pharm X; 2022 Dec; 4():100127. PubMed ID: 36177093
[TBL] [Abstract][Full Text] [Related]
6. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
8. The origin of neural stem cells impacts their interactions with targeted-lipid nanocapsules: Potential role of plasma membrane lipid composition and fluidity.
Carradori D; Dos Santos AG; Masquelier J; Paquot A; Saulnier P; Eyer J; Préat V; Muccioli GG; Mingeot-Leclercq MP; des Rieux A
J Control Release; 2018 Dec; 292():248-255. PubMed ID: 30408552
[TBL] [Abstract][Full Text] [Related]
9. Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Audrey G; Claire LC; Joel E
Int J Pharm; 2021 Aug; 605():120811. PubMed ID: 34144141
[TBL] [Abstract][Full Text] [Related]
10. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
[TBL] [Abstract][Full Text] [Related]
11. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
12. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
[TBL] [Abstract][Full Text] [Related]
14. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Fressinaud C; Thomas O; Umerska AM; Saulnier P
Neurochem Res; 2020 Nov; 45(11):2732-2748. PubMed ID: 32910302
[TBL] [Abstract][Full Text] [Related]
15. Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptide as a promising drug delivery system.
Jourdain MA; Dupont A; Lautram N; Eyer J
Int J Pharm; 2024 Mar; 652():123805. PubMed ID: 38237710
[TBL] [Abstract][Full Text] [Related]
16. Characterization of different functionalized lipidic nanocapsules as potential drug carriers.
Sánchez-Moreno P; Ortega-Vinuesa JL; Martín-Rodríguez A; Boulaiz H; Marchal-Corrales JA; Peula-García JM
Int J Mol Sci; 2012; 13(2):2405-2424. PubMed ID: 22408461
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
[TBL] [Abstract][Full Text] [Related]
18. Layer-by-layer surface modification of lipid nanocapsules.
Hirsjärvi S; Qiao Y; Royere A; Bibette J; Benoit JP
Eur J Pharm Biopharm; 2010 Oct; 76(2):200-7. PubMed ID: 20656028
[TBL] [Abstract][Full Text] [Related]
19. Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules.
Umerska A; Matougui N; Groo AC; Saulnier P
Int J Pharm; 2016 Jun; 506(1-2):191-200. PubMed ID: 27113868
[TBL] [Abstract][Full Text] [Related]
20. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
